Healthcare provider profile · identity verified

Hal Leslie Meadows, MD

Family Practice · SUSANVILLE, CA · NPI 1538233135

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	286	46
Levothyroxine Sodium	Levothyroxine Sodium	260	77
Atorvastatin Calcium	Atorvastatin Calcium	237	72
Losartan Potassium	Losartan Potassium	213	66
Amlodipine Besylate	Amlodipine Besylate	211	67
Lisinopril	Lisinopril	175	47
Metformin Hcl	Metformin Hcl	156	50
Gabapentin	Gabapentin	138	36
Hydrochlorothiazide	Hydrochlorothiazide	125	35
Omeprazole	Omeprazole	122	40
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	115	17
Tamsulosin Hcl	Tamsulosin Hcl	98	32
Alprazolam	Alprazolam	97	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	89	25
Ozempic	Semaglutide	87	23
Temazepam	Temazepam	85	15
Albuterol Sulfate Hfa	Albuterol Sulfate	83	30
Pantoprazole Sodium	Pantoprazole Sodium	83	27
Metoprolol Succinate	Metoprolol Succinate	80	31
Potassium Chloride	Potassium Chloride	80	28
Fenofibrate	Fenofibrate Nanocrystallized	79	25
Zolpidem Tartrate	Zolpidem Tartrate	76	13
Furosemide	Furosemide	72	25
Tramadol Hcl	Tramadol Hcl	70	12
Lovastatin	Lovastatin	66	22
Cephalexin	Cephalexin	65	52
Baclofen	Baclofen	63	21
Ibuprofen	Ibuprofen	62	26
Esomeprazole Magnesium	Esomeprazole Magnesium	60	20
Allopurinol	Allopurinol	59	17
Simvastatin	Simvastatin	58	19
Metoprolol Tartrate	Metoprolol Tartrate	57	19
Lorazepam	Lorazepam	55	13
Rosuvastatin Calcium	Rosuvastatin Calcium	54	16
Meloxicam	Meloxicam	52	16
Synthroid	Levothyroxine Sodium	52	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	17
Sertraline Hcl	Sertraline Hcl	48	16
Clopidogrel	Clopidogrel Bisulfate	47	13
Eliquis	Apixaban	47	14
Atenolol	Atenolol	46	11
Amitriptyline Hcl	Amitriptyline Hcl	43	11
Carvedilol	Carvedilol	41	13
Jardiance	Empagliflozin	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	14
Methocarbamol	Methocarbamol	38	suppressed
Trazodone Hcl	Trazodone Hcl	37	13
Gemfibrozil	Gemfibrozil	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	21
Estradiol	Estradiol	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Naproxen	Naproxen	25	suppressed
Azithromycin	Azithromycin	24	23
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Oxycontin	Oxycodone Hcl	24	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	24	suppressed
Glipizide	Glipizide	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Telmisartan	Telmisartan	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	15
Fluconazole	Fluconazole	21	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Finasteride	Finasteride	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Premarin	Estrogens, Conjugated	18	suppressed
Amoxicillin	Amoxicillin	17	14
Celecoxib	Celecoxib	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Levofloxacin	Levofloxacin	17	15
Spironolactone	Spironolactone	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Armour Thyroid	Thyroid,pork	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Ondansetron Odt	Ondansetron	16	12
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Famotidine	Famotidine	13	suppressed
Np Thyroid	Thyroid,pork	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diazepam	Diazepam	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Jublia	Efinaconazole	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error